Objectives: Delayed and nonunion of the tibia are not uncommon in orthopaedic practice. Multiple methods of treatment have been developed with variable results. The objective of this study was to define disease-specific and treatment-related factors of prognostic significance in patients undergoing shock wave therapy for tibia nonunion.
INTRODUCTION
Nearly 1.5 million of the 6 million fractures treated each year in the United States involve long bones, and nearly one third of these long bone fractures involve the tibia.
1 3 A recent meta-analysis estimated the combined prevalence of tibia nonunions at 2.5% making it the most frequent long bone nonunion. 4 The lack of surrounding muscle on the anterior medial boarder of the tibia is thought to make it more susceptible to nonunion. Tibia nonunion, a result of cessation of periosteal and endosteal healing without fracture bridging, contributes significantly to functional limitations, treatmentrelated morbidity, and healthcare costs. Tibia nonunions are notoriously refractory to treatment and often require multiple interventions over a period of months to years. The result is a large financial burden in both direct costs reflected by hospital and trauma system resource consumption as well as indirect personal costs of rehabilitation and lost productivity resulting from pain, functional deficits, and immobility. 5 • 6
The treatment of tibia nonunion remains highly individualized, complex, and demanding. Treatment options depend on the mechanical and biologic nature of the nonunion and include stabilization when indicated, correction of defom1ity, eradication of infection, soft tissue coverage, and staged bone grafting. 7 9 The prolonged natural history of tibia nonunions has engendered innovative and alternative treatment approaches, including mechanical and molecular interventions in the fonn of nail dynamization, exchange nailing, . WORK UNIT NUMBER
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Approved for public release; distribution unlimited 13 18 24 A promising technology, extracorporeal shock wave therapy (ESWT), has been used to treat various musculoskeletal afflictions, including calcific tendinopathy of the rotator cuff, lateral epicondilitis, and chronic plantar fasciopathy. 25 -· 33 Mechanistic studies support a positive influence of shock waves on osseous biology through enhanced biomechanical properties (increased bone mass and strength) and angiogenesis (shock wave stimulated osteoblast vascular endothelial growth factor-A and ERK-dependent activation of hypoxiainduced factor-1 alpha) in addition to augmented osteogenic differentiation of mesenchymal stem cells (through transfanning growth factor-J3-I and superoxide induced ERKdependent activation of osteogenic transcription, CBFA I). 34 -39 Preliminary clinical data suggested that biophysical stimulation through high-energy shock wave therapy might be a safe and effective alternative treatment for delayed and nonunion of long bones.
40
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2 Our early experience with tibia nonunions demonstrated a favorable response and side effect profile with ESWT. 42 The current analysis is an expansion of a previous study and was conducted on a larger, wellcharacterized patient cohort with tibia nonunions that were treated consecutively and followed at a single institution specializing in the treatment of long bone nonunion with ESWT. 42 In this study, we aim to define disease-specific and treatment-related factors of prognostic significance in patients undergoing shock wave therapy for tibia nonunion.
PATIENTS AND METHODS
General
This retrospective study analyzed 192 consecutive patients with tibia nonunions treated at AUVA-Trauma Center during the time period December 1998 to June 2004. These constituted all patients with nonunions seen in this center during this time period. The study was approved by the Institutional Review Board and written informed consent provided by each study participant.
Clinical and Radiologic Assessment
Clinical covariates investigated in this study included patient age, gender, primary presentation, and involved segment of tibia. Fracture location was defined according to proximal metaphyseal, middiaphyseal, and distal third of the tibia. Fracture healing was assessed on the basis of clinical and radiographic criteria. Clinical assessment for nonunion included pain on weightbearing, pain on palpation or manual bending of the fracture site, or mobility of the fracn1re site. Radiographic assessment and response to treatment was made primarily with anterior-posterior and lateral radiographs. variables assessed included callus presence and size, bony trabecular bridging, and progressive opacification of the fracture line. Successful healing outcome was determined by re-establishment of cortical continuity on three of four cortices at a minimum. Computed tomography (CT) was also obtained for selected cases in which plain radiographs failed to assess adequately the quality of fracture union. Those fractures that demonstrated insufficient healing on CT were included in the study. Subsequent CT scans and/or stress radiographs were obtained when fi11cn1re healing was difficult to assess on plain radiographs, again with successful healing determined by reestablishment of cortical continuity on at least three of four cortices. Magnetic resonance imaging was used to evaluate suspected infected nonunions to assess tor osteomyelitis, abscess, related sinus tracts, and sequestra. Magnetic resonance imaging was not used for assessment of bone healing.
Routine laboratory values such as white blood cell count, erythrocyte sedimentation rate, and C-reactive protein were used to both detem1ine the presence of and assess the adequacy of treatment of osteomyelitis. Plain radiographs were evaluated by board-certified trauma surgeons. whereas CT and magnetic resonance imaging studies were evaluated independently by board-certified radiologists experienced with osseous pathology and radiology.
Demographics and Definitions
We categorized nonunion based on the date of the fracture injury. Nonw1ion was defined as a fracture that: I) has failed to demonstrate cortical continuity on three of four cortices despite operative or nonoperative intervention for 6 months or more; or 2) showed no radiographic changes for 3 consecutive months and was associated with inability to bear weight on the affected extremity, pain on palpation, or motion at the fracture site 6 months posttrauma.
This definition of nonunion was based on not only local practice referral f:,ruidelines, but also based on review by the US Department of Health and Human Services Technology Assessment of bone growth-stimulating devices. 44 Tibia fractures were categorized as open or closed, and the etiologic basis of the nonunion was defined as fracture (nonsurgical traumatic disruption of the tibia) or osteotomy (surgical division or segmental resection of the tibia). Fractures were characterized according to radiographic correlates of underlying biology. 45 Hypertrophic nonunions were those with seemingly viable, well-perfused bone ends demonstrating abundant callus formation but inadequate mechanical stability. Atrophic nonunions were those with impaired osseous biology evident as diminished callus formation or osteopenia on radiographs. Infected nonunions were defined by clinical presentation (fever, open draining sinus. local erythema, edema, callor), laboratory evaluation (leukocytosis, elevated erythrocyte sedimentation rate, C-reactive protein, and positive bacteriolob'Y or histology), and/or radiologic findings (sequestra, progressive bone loss).
Treatment
The majority of patients referred to our institution for tibia nonunion had one or more prior orthopaedic operations and/or adequate immobilization; hence. the population is referral-based and represents largely those with fractures rerraetory to surgical treatment. The principal aim of ESWT was fracture union in anatomic position with restoration of function. Potential study subjects with coagulopathy, nonunions in proximity to the epiphyseal growth plate, malignant nnnor in the shock wave focus. active infec tion (fever greater than 38°C, C-reactive protein greater than 5 mgldl , white blood cell count greater than 12,000 K/U L), and/or pregnancy were not treated with ESWT. Inclusion criteria were those patients with ti bia fractures and nonun ion refe rred to the Trauma Center ;d1er failure of previous therapy based on the treatment patterns of the referring orthopaedic surgeons.
ESWT was administered using the OssnTron device (High Med ical Technologies, Lengwil, Switzerland). Treatment was administered under general or regional anesthesia after operati ve intervention for the associated wound, infection. or fracture (if ind icated). Patients were positioned on the operati ng table such that the fracture li ne was clearly visualized in the anterior-posterior fl uoroscopic projection. The extremity to be treated was placed in such a way that the ESWT head could be positioned to focus the shock wave at the fracture site with the simultaneous use of an image intensifier (BV 25; Philips. Eindhoven, The etherlands). The ESWT trajectory was chosen to avo id nearby neurovascular stmcntres. The focal po int was confirmed to target the fracture site using fluoroscopy (r:ig. I). The tota l number of pulses was divided equa lly along the proximal and di stal margi ns of the nonunion. If shock wave-altering implants was present at the ITacntre point. the shock wave direction was selected in such a way that the implants did not shield the energy fro m the ITacture.
Fractures were treated with a max imum of 12,000 pulses (median. 4000 pu lses ) using a vo ltage of 26 to 28 kV for all treatments corresponding to an energy fl ux density 0.38 to 0.40 mJ/nun 2 . Treatment lasted approximately 20 to 60 FIGURE 1. Positioning of extracorporeal shock wave therapy. Patients were positioned on the operating table such that the fracture line was clearly visualized in the anteriorposterior fluoroscopic projec tio n. The extremity to be treated was placed to focus the shock wave at the fracture site with the simu ltaneous use of an image intensifier. The focal poin t was confirmed to target the fracture site using fluoroscopy.
Extracorporeal Shock Wave Therapy minutes, di rectly proportional to the pulse sequences delivered. ESWT intensity applied was selected initially up to 12,000 pulses with subsequent decrease to 4000 pulses after intemal review of outcomes at various pulse dose intensities and when other preclinical studies demonstrated an optimal treatment effect at a dose of 4000 pulses.~• After ESWT, the limb was treated in one of three ways:
immobilization with a plaster cast or plastic splint (n = I 74), placement of an ex ternal fixa tor (n = I 0) in cases in which the nonunion had excessive mobility (greater than 15° of angulation on acti ve fl uoroscopic examination), or no add itional immobilization given implant stabil ity (n = 8). Plastic splints were chosen for multiply injured patients as well as elderly patients because of their lighter weight and greater comfo rt. The durati on of immob il ization (up to I 2 weeks) was not standardized and wns selected individually based on the fracture location and classi fi cation. frc1crure gap and stabi lity, lower extremi ty alignment. and presence of underlyi ng infection. Patients without frac ture mobility were treated with either immobilization or part ial to no weightbeari ng for 3 to 6 weeks.
Da ta
The primary outcome was frJcturc healing. r:ractu rc heal ing was defined as patient abi lity to bear fu ll weight on the affected limb, absence of pain at the fracture si te on manual bending or compression, and rad iographic re-establ ishment of cortica l continuity on three of fo ur cortices with increasing bony trabecular bridging the fracrure site on plain radiographs. For CT scans, fracn1re healing was detem1ined to be successful if trabecular bridging or the frac ture si te was seen in at least three of four cortices. Time to heal ing was assessed from the date of the fi rst ESWT to the date of documented ITacture heali ng. The length of the follow-up period was calculated from the time of last orthopaedic opera tion ( 
RESULTS
Study Population
Between January 1990 and February 2004, 192 predominantly male (n = 140) patients with a tibial nonunion after fracture (n = 185) or osteotomy (n = 7) were referred to Trauma Center Meidling. Mean age for the study population was 44.6 ± 14.4 years (median, 44 years; range, 16-90 years). 
Operative and Shock Wave Interventions
Over 90% (n = 175) of patients underwent one or more orthopaedic operative interventions, including periods of immobilization before focused shock wave therapy (mean, 2.4 ::!:: 1.9; median, 2; range. 1-10). These are summarized in Table I . Most patients had one shock wave treatment (n = 153 [79.7%]), 29 (15.1%) .had two, and nine (4.7%) underwent three treatments. One patient was treated on four occasions with ESWT. Mean total shock wave dose administered for the study population was 5510 ± 3610 (median, 4000; range, 2000-12,000) impulses at energy flux density of 0.38 to 0.40 mJ/mm 2 • Thirty-three (17.2%) patient.;; underwent subsequent orthopaedic operative procedures, primarily dynamization (n = I 1), hardware removal (n = 7), or external fixation (n = 4) as shown in Table I . At final post-ESWT follow up, 28 of these 33 (84.8%) patients who underwent post-ESWT operative procedures demonstrated complete fracture healing.
Patient Follow Up and Fracture Healing
Twenty of 192 patients have incomplete follow-up information and were not included in the subsequent analysis. Hence, the study population is based on 172 patients with complete treatment and follow-up information (Table 2) . There were no major adverse side effects associated with shock wave therapy or the subsequent period of immobilization. Typical well-established minimal treatment-related side effects were observed infrequently and appeared to be dose-related: local edema, cutaneous petechial hemorrhage, and subcutaneous hematoma (range, 1-5 mm in greatest dimension). Local soft tissue edema, petechiae, and hematomas in the treated field resolved spontaneously without incident within 3 to 7 days. No worsening in established chronic infection was observed during ESWT and posttreatment follow up. A were significan tly associated with complete bone healing ( Table 2 ). The significantly lower likelihood off'ract\lre heal ing in patients requiring multip le (more than one) shock wave treatments versus a single treatment may be attributable to the 
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DISCUSSION
Focused shock wave therapy has been used since the early 1990s in Europe and Asia for the treatment of nonunions with reported healing rates between 55% and 80%; however, this treatment modality has not gained widespread acceptance in the United States.
'
41 -4 3 .4 5 -48 The current approach in the United States to this challenging problem focuses on initial control of infection, if present, followed by fracture stabilization, if indicated, and bone grafting augmented by recombinant bone morphogenic proteins or bone growthstimulating devices such as ultrasound or electromagnetic devices. ESWT as well as ultrasound therapy and pulsed electromagnetic field stimulation are modalities that deliver targeted physical enert:,'Y to produce the desired biologic effect of osseous healing. Although the exact mechanism underlying this mechanotransduction has yet to be elucidated precisely, migration and differentiation of mesenchymal stem cells and promotion of angiogenesis are thought to contribute increased bone mass and strength. 34 -39 Previous studies have reported 15 years' worth of clinical experience in Europe and Asia with ESWT for the treatment of fracture nonunions. These studies have been both retrospective and prospective in design and have included anywhere from 43 to 72 long bones treated with a variety of ESWT devices and varying degrees of posttreatment immobilization in heterogeneous populations. In contrast to studies reported using ultrasound or pulsed electromagnetic field stimulation, the patients in the ESWT studies underwent largely a single ESWT. The percentage of bony union, assessed by a combination of clinical and/or radiographic findings, after ESWT ranged from 55% to 87%. Our previously reported pilot study, which included 34 tibia fracture nonunions, demonstrated a healing rate of 76% and serves as the basis for the current study.
42
This is the largest cohort of tibia nonunions reported to date treated at a single institution. The study was designed to assess the ability of ESWT to promote fracture union and restore limb function. In addition, we have attempted to elucidate the disease and treatment-related factors of prognostic significance in patients undergoing shock wave therapy for nonunion of the tibia. As such, we suggest that focused ESWT followed by fracture immobilization delivered in one brief treatment session (median total shock wave dose of 4000 pulses) in the majority of patients is associated with an 80% rate of nonunion healing as assessed by both clinical and radiographic means. These data suggest ESWT is both a safe and feasible treatment modality for tibia nonunion.
The study population consisted mainly of patients with tibia nonunion refractory to surgical treatment and/or immobilization (ie, negative selection bias). Median time to healing from last orthopaedic operation was 14 months with a mean follow-up period of nearly 16 months. The average time to healing after ESWTwas 4.8 months. Follow up did not extend beyond documented nonunion healing in many cases, because these patients were treated under a Workmen's Compensation program and were released once treatment was completed and fracture healing and functional improvement documented. However, the follow-up time period in
Extracorporeal Shock Wave Therapy this study represents a significantly longer follow-up period than previously reported in the literature with the majority of patients in this study demonstrating healing according to defined objective criteria within the first 6 months of shock wave treatment. 45 .4
9 Despite the negative selection bias inherent in the study population, fracture healing 3 and 6 months after completion of shock wave therapy was 67% and 80%, respectively. Like with previously reported studies, fracture immobilization and stabilization were considered vital components ofpost-ESWT therapy and were incorporated into the study treatment protocol. Outcomes were unrelated to both the type (P = 0.60) and duration (P = 0.32) of post-ESWT immobilization. It is also important to note that although 33 patients in this series underwent concurrent ESWT orthopaedic procedures (eg, dynamization, hardware removal, external fixator placement), there was no difference is the rate of healing in this particular subset of patients (P = 0.54).
The factors significantly associated with bony healing were related to number of treatment interventions. Increasing number of both orthopaedic operations before ESWT as well as number of postinjury shock wave treatments initiated after failed operation(s) correlated with failure of nonunion healing. Type, location, etiology, and pathology of nonunion as well as other treatment-related factors were not independently related to fracture healing. Like with our experience in treating soft tissue injuries with ESWf, early intervention before multiple treatment procedures was associated with greater therapeutic success than with delayed intervention with shock waves after demonstrated non-ESWT therapeutic futility. Multiple prior operative interventions for nonunion correlating with decreased success with ESWT likely relate to the severity of injury and/or periosteal disruption and impaired perfusion stemming from operative trauma. These findings suggest early referral and treatment with ESWT for nonunions may result in improved outcome and should serve as the basis for future controlled clinical trials.
Limitations of this study include those inherent to retrospective, nonrandomized study designs; however, its primary limitation is the lack of a control group to distinguish the effect of immobilization from the shock wave treatment itself. Related to the retrospective nature of the study is the loss of 20 patients to follow up. Although these patients were demographically similar to the remaining 172 patients, bias can be introduced in the analysis that may be ameliorated by a prospective study. A further limitation of this, and all studies concerning osseous nonunion, is the actual definition of "nonunion." Although not uniformly agreed on, our use of the 6-month criterion for defining nonunion was based on several factors. The local treatment practice guidelines in the standardized healthcare system in Austria limit the nonoperative management of nonunion to 6 months, therefore limiting our referral population to this time point. In addition, the 6-month definition of nonunion has been adopted by some regulatory bodies and provides further substantiation of the 6-month defining threshold used by our group. 44 Finally, as a result of the nature of our referral population, the antecedent treatment course was not controlled for but followed national standards of practice focused on surgical intervention and/or immobilization of the long-bone nonunion.
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In summary, we describe the largest patient population reported to date treated successfully with ESWT for a representative group of tibia nonunions. These results were achieved in most cases with a single ESWT session coupled with standard-of-practice fracture immobilization techniques. Successful treatment outcome (healing of the nonunion) was associated with well-defined inherent predictive factors: frequency and intensity of both orthopedic and shock wave treatment. The most promising results arising from this study involve the treatment of atrophic nonunions. It is generally accepted that atrophic nonunions do not heal with immobilization alone, suggesting that the treatment effect seen in this subset of patients is a result of shock wave therapy. 46 -48 This report adds to the growing body of literature, suggesting that physical energy delivered in the form of shock wave therapy has a direct biologic effect in promoting tissue and bone repair. 49 53 Mechanistic studies are underway to elucidate this effect.
